Among the various mediators, Th2-induced cytokines (e.g., IL-4, -13, and -31) are major contributing factors of AD; therefore, targeting Th2-mediated immune reactions has been one of the main strategies for AD therapy [3]. Here, IL4 is linked to Alzheimer disease.